1.22
price up icon5.17%   0.06
after-market Handel nachbörslich: 1.13 -0.09 -7.38%
loading
Schlusskurs vom Vortag:
$1.16
Offen:
$1.2
24-Stunden-Volumen:
131.89K
Relative Volume:
0.11
Marktkapitalisierung:
$162.56M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-18.86M
KGV:
-0.076
EPS:
-16.054
Netto-Cashflow:
$-17.68M
1W Leistung:
+7.02%
1M Leistung:
-10.29%
6M Leistung:
-39.30%
1J Leistung:
-73.54%
1-Tages-Spanne:
Value
$1.17
$1.235
1-Wochen-Bereich:
Value
$1.09
$1.235
52-Wochen-Spanne:
Value
$0.92
$8.57

Indaptus Therapeutics Inc Stock (INDP) Company Profile

Name
Firmenname
Indaptus Therapeutics Inc
Name
Telefon
(646) 427-2727
Name
Adresse
3 COLUMBUS CIRCLE, NEW YORK
Name
Mitarbeiter
5
Name
Twitter
Name
Nächster Verdiensttermin
2026-08-12
Name
Neueste SEC-Einreichungen
Name
INDP's Discussions on Twitter

Compare INDP vs VRTX, REGN, ARGX, MRNA, RVMD

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
INDP icon
INDP
Indaptus Therapeutics Inc
1.22 183.87M 0 -18.86M -17.68M -16.05
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
546.12 136.93B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
827.72 85.11B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
1,033.15 64.95B 4.16B 1.29B 734.26M 19.58
MRNA icon
MRNA
Moderna Inc
145.55 53.23B 2.23B -3.19B -1.60B -8.1462
RVMD icon
RVMD
Revolution Medicines Inc
210.02 45.38B 742.00K -1.37B -1.07B -7.0731

Indaptus Therapeutics Inc Aktie (INDP) Neueste Nachrichten

pulisher
Sep 04, 2026

Indaptus Therapeutics Announces Routine Board Member Resignation - TipRanks

Sep 04, 2026
pulisher
Sep 04, 2026

Indaptus Therapeutics, Inc. Announces Resignation of Tim Ruan from Director, Effective September 2, 2026 - marketscreener.com

Sep 04, 2026
pulisher
Sep 01, 2026

Indaptus Updates ATM Agreement to Expand Capital Flexibility - TipRanks

Sep 01, 2026
pulisher
Sep 01, 2026

Indaptus Therapeutics Launches $100 Million ATM Equity Program With H.C. Wainwright - TradingView

Sep 01, 2026
pulisher
Sep 01, 2026

Indaptus sets up $100M at-the-market stock program - Stock Titan

Sep 01, 2026
pulisher
Aug 31, 2026

Indaptus Therapeutics Launches $100M ATM Offering at $1.14 Per Share (NASDAQ: INDP) - Kalkine Media

Aug 31, 2026
pulisher
Aug 26, 2026

Indaptus Therapeutics, Inc. SEC Filing (Aug 26, 2026) - Stock Titan

Aug 26, 2026
pulisher
Aug 20, 2026

12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga

Aug 20, 2026
pulisher
Aug 14, 2026

Indaptus Therapeutics Stock Price Forecast. Should You Buy INDP? - StockInvest.us

Aug 14, 2026
pulisher
Aug 14, 2026

Indaptus Therapeutics Inc (NASDAQ: INDP) Share Price, INDP Stock News, INDP Share Price & Updates - Kalkine

Aug 14, 2026
pulisher
Aug 14, 2026

Short Interest in Indaptus Therapeutics, Inc. (NASDAQ:INDP) Declines By 64.1% - MarketBeat

Aug 14, 2026
pulisher
Aug 13, 2026

Indaptus Therapeutics Releases Q2 2026 Financial Results - AlphaStreet

Aug 13, 2026
pulisher
Aug 13, 2026

Indaptus Therapeutics Q2 EPS beats estimate as loss narrows - scanx.trade

Aug 13, 2026
pulisher
Aug 13, 2026

Indaptus Therapeutics Reports Q2 Results Amid Strategic Pivot - TipRanks

Aug 13, 2026
pulisher
Aug 13, 2026

Indaptus Therapeutics, Inc. 2Q 2026: Net loss $(1.79M), EPS $(0.02) — 10-Q Summary - TradingView

Aug 13, 2026
pulisher
Aug 13, 2026

Indaptus Therapeutics (Nasdaq: INDP) cuts losses and raises $12M in Q2 - Stock Titan

Aug 13, 2026
pulisher
Aug 13, 2026

Indaptus Q2 Net Loss Narrows to $1.8 Million - Quiver Quantitative

Aug 13, 2026
pulisher
Aug 13, 2026

Indaptus Therapeutics (INDP) slashes R&D costs and bolsters cash after $12M raise - Stock Titan

Aug 13, 2026
pulisher
Aug 13, 2026

Indaptus Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update - The Manila Times

Aug 13, 2026
pulisher
Aug 13, 2026

Indaptus Therapeutics (INDP) Falls 14% to $1.02 — Biotech Micro-Cap Tests Critical SupportDescending Triangle - vinanet.vn

Aug 13, 2026
pulisher
Aug 12, 2026

Indaptus Therapeutics Inc (INDP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Aug 12, 2026
pulisher
Aug 11, 2026

Indaptus Therapeutics (INDP) Q4 2025 Earnings: Wider-than-Expected Loss Amid No RevenueReturn On Equity - dars.gov.et

Aug 11, 2026
pulisher
Aug 10, 2026

Indaptus Therapeutics (INDP) to Announce Earnings on Monday - MarketBeat

Aug 10, 2026
pulisher
Aug 07, 2026

Qinglai Lu Net Worth (2026) - GuruFocus

Aug 07, 2026
pulisher
Aug 07, 2026

Indaptus Therapeutics Inc (INDP) Stock News Today - TradingKey

Aug 07, 2026
pulisher
Aug 02, 2026

Indaptus Therapeutics (INDP) Slides 10.4% — Approaches Key Support at $1.23Ichimoku Entry - vinanet.vn

Aug 02, 2026
pulisher
Aug 01, 2026

Indaptus Therapeutics (INDP) Slides 10.4% as Clinical-Stage Biotech Faces Selling PressureIchimoku Kumo Twist - vinanet.vn

Aug 01, 2026
pulisher
Jul 30, 2026

INDP Q4 2025 Earnings: Wider-Than-Expected Loss Sends Shares Down 20.88%EPS Surprise History - vinanet.vn

Jul 30, 2026
pulisher
Jul 27, 2026

Indaptus Therapeutics Inc (INDP) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

INDP|Indaptus Therapeutics Inc|Price:2.610|Chg%:-0.160 - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Indaptus Therapeutics Inc (INDP) Balance Sheet - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Indaptus Therapeutics (INDP) Plunges 21% – Key Support Levels in FocusMFI Divergence - vinanet.vn

Jul 27, 2026
pulisher
Jul 26, 2026

Indaptus Therapeutics Inc (INDP) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jul 26, 2026
pulisher
Jul 26, 2026

Indaptus Therapeutics Inc (INDP) Cash Flow - TradingKey

Jul 26, 2026
pulisher
Jul 26, 2026

Indaptus Therapeutics Market Sentiment - Benzinga España

Jul 26, 2026
pulisher
Jul 26, 2026

Indaptus Therapeutics Inc (INDP) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jul 26, 2026
pulisher
Jul 26, 2026

Indaptus Therapeutics Inc (INDP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jul 26, 2026
pulisher
Jul 26, 2026

INDP|Indaptus Therapeutics Inc|Price:2.060|Chg%:-0.550 - TradingKey

Jul 26, 2026
pulisher
Jul 26, 2026

Indaptus Therapeutics, Inc. Revenue Breakdown – NASDAQ:INDP - TradingView

Jul 26, 2026
pulisher
Jul 25, 2026

Indaptus Therapeutics Inc (INDP) Institutional Confidence - TradingKey

Jul 25, 2026
pulisher
Jul 25, 2026

TradingKey - TradingKey

Jul 25, 2026
pulisher
Jul 25, 2026

INDP Q4 2025 Earnings: EPS Misses Estimates as Clinical-Stage Biotech Faces Steep Stock DeclineConsensus Beat Rate - vinanet.vn

Jul 25, 2026
pulisher
Jul 24, 2026

Indaptus Therapeutics Inc (INDP) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jul 24, 2026
pulisher
Jul 23, 2026

INDP Q4 2025 Earnings: EPS Falls Short of Estimates, Stock Rises Amid Pipeline ProgressHigh Growth Earnings - vinanet.vn

Jul 23, 2026
pulisher
Jul 21, 2026

Indaptus Therapeutics (INDP) Q3 2025 earnings summary - Quartr

Jul 21, 2026
pulisher
Jul 21, 2026

Signal Proxy Intelligence Recommends Full Support for All Three Items at Indaptus Therapeutics, Inc. Annual Meeting - trinidadexpress.com

Jul 21, 2026
pulisher
Jul 20, 2026

Indaptus Therapeutics, Inc. SEC Filing (Jul 20, 2026) - Stock Titan

Jul 20, 2026
pulisher
Jul 19, 2026

INDP Q4 2025 Earnings: EPS Misses Estimates Amid Continued R&D InvestmentOperating Margin Analysis - vinanet.vn

Jul 19, 2026
pulisher
Jul 16, 2026

Indaptus Therapeutics (NASDAQ: INDP) seeks approval for 2026 equity plan - Stock Titan

Jul 16, 2026
pulisher
Jul 16, 2026

INDP Q4 2025 Earnings: Wider-than-Expected Loss as Pre-Revenue Biotech Navigates Clinical Development - vinanet.vn

Jul 16, 2026
pulisher
Jul 08, 2026

Insider Traders Lose US$34k As Indaptus Therapeutics Drops - simplywall.st

Jul 08, 2026

Finanzdaten der Indaptus Therapeutics Inc-Aktie (INDP)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$103.76
price up icon 0.86%
$126.29
price down icon 0.31%
$63.96
price up icon 0.13%
$266.11
price up icon 0.61%
ONC ONC
$358.26
price down icon 1.22%
$210.02
price down icon 0.40%
Kapitalisierung:     |  Volumen (24h):